Histological, molecular and functional subtypes of breast cancers

In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis

(2010) Veronique Neumeister et al.   AMERICAN JOURNAL OF PATHOLOGY

Combinatorial biomarker expression in breast cancer

(2010) Emad A. Rakha et al.   BREAST CANCER RESEARCH AND TREATMENT

Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content

(2010) Salvatore Pece et al.   CELL

Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer

(2010) S. Y. Park et al.   CLINICAL CANCER RESEARCH

Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate

(2010) X. Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment

(2009) Erika Resetkova et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

(2009) Emmanuelle Charafe-Jauffret et al.   CANCER RESEARCH

Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers

(2009) T. Tanei et al.   CLINICAL CANCER RESEARCH

Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis

(2009) Jane E. Visvader   GENES & DEVELOPMENT

Reply to C. Badoual et al

(2009) Paul Salama et al.   JOURNAL OF CLINICAL ONCOLOGY

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

(2009) Elgene Lim et al.   NATURE MEDICINE

Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer

(2008) J. S. Ross et al.   ONCOLOGIST